An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer

Annals of Oncology

Volumn 23, Issue 7, 2012, Pages 1756-1765

  Danese, M D ^a   O'Malley, C ^b   Lindquist, K ^a   Gleeson, M ^a   Griffiths, R I ^a,c  

^a Outcomes Insights Inc   (United States)

^b AMGEN INC   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse events disclosures; Breast cancer; Comorbidity

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER STAGING; CARCINOMA IN SITU; COMORBIDITY; CONTROLLED STUDY; DRUG ERUPTION; ELECTROLYTE DISTURBANCE; ETHNICITY; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; INCIDENCE; INFECTION; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; ORAL MUCOSITIS; PREVALENCE; PRIORITY JOURNAL; RACE; RASH; RHEUMATIC DISEASE; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; LIVER DISEASES; LONGITUDINAL STUDIES; OFFICE VISITS; OSTEOARTHRITIS; PREVALENCE; UNITED STATES;

EID: 84864314664     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr486     Document Type: Article

References (42)

1. American Cancer Society. Breast Cancer Facts & Figures 2009-2010 [Internet] Atlanta, GA: American Cancer Society, Inc. 2009 http://www.cancer.org/downloads/STT/F861009_final%209-08-09.pdf (21 May 2010, date last accessed).
2. National Cancer Institute. SEER Stat Fact Sheets: Breast [Internet] Bethesda, MD: National Cancer Institute 2010. http://seer.cancer.gov/statfacts/html/breast.html (21 May 2010, date last accessed).
3. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120(2): 104-110.
4. Yancik R, Wesley MN, Ries LA et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285(7): 885-892.
5. Klabunde CN, Legler JM, Warren JL et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007; 17(8): 584-590.
6. Lewis JH, Kilgore ML, Goldman DP et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21(7): 1383-1389.
7. Gornick ME, Eggers PW, Riley GF. Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. Health Serv Res 2004; 39(5): 1403-1427.
8. Keating NL, Landrum MB, Ayanian JZ et al. The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 2005; 20(1): 38-44.
9. Tromp DM, Brouha XD, Hordijk GJ et al. Medical care-seeking and health-risk behavior in patients with head and neck cancer: the role of health value, control beliefs and psychological distress. Health Educ Res 2005; 20(6): 665-675.
10. Warren JL, Klabunde CN, Schrag D et al. Overview of the SEER-medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40(Suppl 8): IV3-IV18.
11. National Cancer Institute. Overview of the SEER Program [Internet]. Bethesda, MD: National Cancer Institute 2010 http://seer.cancer.gov/about/ (21 May 2010, date last accessed).
12. National Cancer Institute. SEER-Medicare: How the SEER & Medicare Data are Linked [Internet]. Bethesda, MD: National Cancer Institute 2010 http://healthservices.cancer.gov/seermedicare/overview/linked.html (21 May 2010, date last accessed).
13. Fritz A, Ries L. SEER Program Code Manual 3rd edition. Bethesda: National Cancer Institute 1998.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-383.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45(6): 613-619.
16. Romano PS, Roos LL, Luft HS et al. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994; 47(3): 249-260.
17. Practice Management Information Corporation. ICD-9-CM, 6th edition. Los Angeles, CA: Practice Management Information Corporation 2005.
18. Practice Management Information Corporation. HCPCS Los Angeles, CA: Practice Management Information Corporation 2005.
19. Rothman KJ, Greenland S. Modern Epidemiology. 2nd edition. Pliladelphia, PA: Lippincott Williams & Wilkins 1998.
20. Hilbe JM. Negative Binomial Regression 2007New YorkCambridge University Press 2007.
21. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edition. London: Chapman and Hall 1998.
22. Rywik SL, Williams OD, Pajak A et al. Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project. J Hypertens 2000; 18(8): 999-1006.
23. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000; 13(1 Pt 2): 3S-10S.
24. de MP, Wutschert R, Heinzmann M et al. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost 1998; 80(2): 239-241.
25. Heit JA, Silverstein MD, Mohr DN et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86(1): 452-463.
26. Narayan KM, Boyle JP, Thompson TJ et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007; 30(6): 1562-1566.
27. Reijman M, Pols HA, Bergink AP et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007; 66(2): 158-162.
28. Grotle M, Hagen KB, Natvig B et al. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 2008; 9: 132.
29. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996; 63(Suppl 3): 437S-441S.
30. McTiernan A. Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S. Cancer 2000; 88(Suppl 5): 1248-1255.
31. Allen NE, Beral V, Casabonne D et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 2009; 101(5): 296-305.
32. Lew JQ, Freedman ND, Leitzmann MF et al. Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study. Am J Epidemiol 2009; 170(3): 308-317.
33. Fleming ST, Pursley HG, Newman B et al. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005; 43(2): 132-140.
34. Vaeth PA, Satariano WA, Ragland DR. Limiting comorbid conditions and breast cancer stage at diagnosis. J Gerontol A Biol Sci Med Sci 2000; 55(10): M593-M600.
35. Gonzalez EC, Ferrante JM, Van Durme DJ et al. Comorbid illness and the early detection of cancer. South Med J 2001; 94(9): 913-920.
36. Tetsche MS, Dethlefsen C, Pedersen L et al. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer 2008; 8: 31.
37. Zafar SY, Abernethy AP, Abbott DH et al. Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer 2008; 8: 345.
38. Mouchawar J, Taplin S, Ichikawa L et al. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?. J Natl Cancer Inst Monogr 2005; 35: 39-46.
39. Badgwell BD, Giordano SH, Duan ZZ et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 2008; 26(15): 2482-2488.
40. Harlan LC, Klabunde CN, Ambs AH et al. Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv 2009; 3(2): 89-98.
41. Fowles JB, Lawthers AG, Weiner JP et al. Agreement between physicians' office records and Medicare Part B claims data. Health Care Financ Rev 1995; 16: 189-199.
42. Warren JL, Klabunde CN, Mariotto AB et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009; 150(12): 849-857.